Search

Your search keyword '"Takotsubo Cardiomyopathy metabolism"' showing total 83 results

Search Constraints

Start Over You searched for: Descriptor "Takotsubo Cardiomyopathy metabolism" Remove constraint Descriptor: "Takotsubo Cardiomyopathy metabolism"
83 results on '"Takotsubo Cardiomyopathy metabolism"'

Search Results

1. Generation of a heterozygous Calsequestrin 2 F189L iPSC line (UMGi158-B) by CRISPR/Cas9 genome editing to investigate the cardiac pathophysiology of Takotsubo Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia.

2. A review of the interplay between Takotsubo cardiomyopathy and adrenal insufficiency: Catecholamine surge and glucocorticoid deficiency.

3. Comparative Analysis of Plasma Protein Dynamics in Women with ST-Elevation Myocardial Infarction and Takotsubo Syndrome.

4. Human cardiac microvascular endothelial cells/α 1 -agonists/endothelial dysfunction: pathophysiologic connotations for takotsubo syndrome.

5. Is premorbid stress assessed by hair cortisol concentration linked to Takotsubo syndrome? Results from a pilot study.

6. Neurometabolic Features of Takotsubo Syndrome: A Brain 18 F-FDG PET Case Control-Prospective Study.

7. The role of inflammation in takotsubo syndrome: A new therapeutic target?

8. Cardiomyocyte NOX4 regulates resident macrophage-mediated inflammation and diastolic dysfunction in stress cardiomyopathy.

9. Calcineurin signaling promotes takotsubo syndrome.

10. Acute stress induces long-term metabolic, functional, and structural remodeling of the heart.

12. Hemorrhagic Cerebral Insults and Secondary Takotsubo Syndrome: Findings in a Novel In Vitro Model Using Human Blood Samples.

13. Metabolic alterations in a rat model of takotsubo syndrome.

14. Takotsubo Syndrome: Translational Implications and Pathomechanisms.

15. Catecholamine-induced cardiotoxicity: A critical element in the pathophysiology of stroke-induced heart injury.

16. Pathophysiology of Takotsubo Cardiomyopathy: Reopened Debate.

17. The role of inflammation in stress cardiomyopathy.

18. SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis.

19. Persistent long-term platelet activation and endothelial perturbation in women with Takotsubo syndrome.

20. Novel Approach to Imaging Active Takayasu Arteritis Using Somatostatin Receptor Positron Emission Tomography/Magnetic Resonance Imaging.

21. Clinical features, complications, and outcomes of exogenous and endogenous catecholamine-triggered Takotsubo syndrome: A systematic review and meta-analysis of 156 published cases.

22. Role of PI3K/AKT/mTOR Pathway Associated Oxidative Stress and Cardiac Dysfunction in Takotsubo Syndrome.

24. Cannabis Use as a Risk Factor for Takotsubo (Stress) Cardiomyopathy: Exploring the Evidence from Brain-Heart Link.

25. No evidence for humoral autoimmunity against cardiomyocytes, adrenergic or muscarinic receptors in patients with Tako-Tsubo cardiomyopathy.

26. Neutrophil-Initiated Myocardial Inflammation and Its Modulation by B-Type Natriuretic Peptide: A Potential Therapeutic Target.

27. Coronary artery myointimal dysplasia in patients with pheochromocytoma-possible causal relationship: pathophysiology and clinical implication with reference to Takotsubo cardiomyopathy and spontaneous coronary dissection.

29. Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human Study.

30. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

31. Toll-like receptor expression and apoptosis morphological patterns in female rat hearts with takotsubo syndrome induced by isoprenaline.

32. Response to letter from Dr. Madias.

33. Correlation between endothelial dysfunction and myocardial damage in acute phase of Tako-Tsubo cardiomyopathy: brachial flow mediated dilation as a potential marker for assessment of patient with Tako-Tsubo.

34. Metabolism and distribution of pharmacological homoarginine in plasma and main organs of the anesthetized rat.

35. Catecholamine-Dependent β-Adrenergic Signaling in a Pluripotent Stem Cell Model of Takotsubo Cardiomyopathy.

37. Contemporary review on the pathogenesis of takotsubo syndrome: The heart shedding tears: Norepinephrine churn and foam at the cardiac sympathetic nerve terminals.

38. The Insular Cortex and Takotsubo Cardiomyopathy.

39. Depiction of the discrepancy between fatty-acid metabolism and myocardial perfusion in takotsubo cardiomyopathy using dedicated cardiac semiconductor gamma camera.

40. I f channel blocker ivabradine vs. β-blockers for sinus tachycardia in patients with takotsubo syndrome.

41. Potential drugs for the management of patients with takotsubo syndrome.

42. Current Concepts in the Pathogenesis of Takotsubo Syndrome.

43. The Sympathetic Nervous System in the Pathogenesis of Takotsubo Syndrome.

44. Metabolic myopathy facilitating the development of Takotsubo syndrome.

45. Chronic obstructive lung disease exacerbation and takotsubo syndrome.

46. Cardiac Dysfunction After Neurologic Injury: What Do We Know and Where Are We Going?

47. Attack the ATAK : "οὓς ὁ θεὸς συνέζευξε, ἄνθρωπος μὴ χωριζέτω" (ous o theos synezeuxe anthropos me horizeto) "what therefore God hath joined together, let not man put asunder".

48. Deletion of low molecular weight protein tyrosine phosphatase (Acp1) protects against stress-induced cardiomyopathy.

49. A possible relationship between Takotsubo cardiomyopathy and female sex steroid-related modulation of functional cerebral asymmetry.

50. Plasma catecholamine levels in patients with takotsubo syndrome: Implications for the pathogenesis of the disease.

Catalog

Books, media, physical & digital resources